Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;30(1):22-25.
doi: 10.1038/s41591-023-02669-x.

Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity

Stephanie W Waldrop #  1 , Veronica R Johnson #  2 , Fatima Cody Stanford  3
Affiliations

Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity

Stephanie W Waldrop et al. Nat Med. 2024 Jan.

Abstract

GLP-1 receptor agonists are effective treatments for obesity but are less accessible worldwide than pharmacological treatments for diabetes, reflecting biases and lack of education, and perpetuating health inequalities.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing interests.

References

    1. Michaelidou M, Pappachan JM & Jeeyavudeen MS World J. Diabetes 14, 396–411 (2023). - PMC - PubMed
    1. Gomez G & Stanford FC Int. J. Obes 42, 495–500 (2018). - PMC - PubMed
    1. Bessesen DH & Van Gaal LF Lancet Diabetes Endocrinol. 6, 237–248 (2018). - PubMed
    1. Washington TB et al. Gastroenterol Clin North Am 52, 429–441 (2023). - PMC - PubMed
    1. Nauck MA & Meier JJ Diabetes Obes. Metab 20, 5–21 (2018). - PubMed

Substances

LinkOut - more resources